The FDA has accepted an investigational new drug application for an investigational and proprietary combination therapy to ...

New safety study links sedative use to increased stroke risk. A large UK study involving more than 165,000 people with dementia has found that the drug risperidone increases the risk of stroke in all ...

You think you’re fine. Your family and friends think you’re fine. But, just maybe, you’re not. Maybe you already have Alzheimer’s disease, but you just don’t know it yet, because it can begin ...

"Neumora’s Alzheimer’s disease agitation drug shows early success in Phase Ib trial" was originally created and published by ...

Coya Therapeutics, Inc. (NASDAQ: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company focused on ...

If you’re a woman of a certain age, your social media feed may be filled with claims that a single therapy will fight ...

Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's ...

A study conducted in Spain and other European countries refines a method to simplify the early diagnosis of the leading cause ...

Company remains focused on potential approval and launch of IGALMI® for the acute treatment of agitation associated with ...

A host of new science books are due to hit shelves in January, by authors including Claudia Hammond, Deborah Cohen and Daisy ...

Foods that interfere with your metabolism can increase inflammation — especially foods high in unhealthy fats and sugar.